Real-world experience of venetoclax target dosing with concomitant posaconazole in adult patients with acute myeloid leukemia

Venetoclax creates ongoing challenges when combined with posaconazole due to a known drug-drug interaction. Herein, we investigated the safety between venetoclax 100mg and 70mg when administered with posaconazole in acute myeloid leukemia in this single-center, retrospective comparative analysis. Pr...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Tracelyn Freeman, Alma Habib, Ying Huang, Pooja S. Kumar, Allyson Waller, Megan Fleming, Kelsey McMillan, Natalia Hartzler, Gregory Behbehani, James S. Blachly, Bradley W. Blaser, Uma Borate, Ann-Kathrin Eisfeld, Nicole R. Grieselhuber, Shivani Handa, Karilyn Larkin, Shinae Lee, Meixiao Long, Alice Mims, Andrew Srisuwananukorn, Jayanshu Jain, Kieran Sahasrabudhe, Kristin Koenig
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-09-01
Edice:	Frontiers in Hematology
Témata:	venetoclax posaconazole leukemia dosing interaction myeloid
On-line přístup:	https://www.frontiersin.org/articles/10.3389/frhem.2025.1664425/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!